How Often Do You Take Wegovy for Weight Loss

What the STEP 1 trial established about weekly dosing

The evidence base for once-weekly semaglutide 2.4 mg comes largely from the STEP programme, with STEP 1, published in the New England Journal of Medicine, being the pivotal paper. Over 68 weeks, adults with obesity injecting once every seven days (alongside lifestyle changes) saw an average body-weight reduction of around 15%. That figure comes from a specific protocol: fixed weekly frequency, a slow five-stage titration, and no improvisation with the interval.

The weekly schedule is not arbitrary. Semaglutide's pharmacokinetics mean the drug accumulates to a steady state within four to five weeks of regular once-weekly dosing. Inject more frequently and you don't get faster results; you get a higher risk of side effects with no clinical rationale. This is a detail the trial design quietly encoded. It's also why the NHS medicines information for semaglutide is unambiguous: once a week, on the same day, each week.

There is a common misconception worth addressing plainly. Some people assume that taking it more often during a plateau might push through it. There is no evidence this helps, and it sits outside the licensed schedule entirely. If you want a fuller explanation of how often you take Wegovy and why that frequency is fixed, the plateau is a physiological response, not a sign the dose frequency needs changing, that conversation belongs with your prescriber.

How the titration schedule unfolds week by week

Treatment starts at 0.25 mg for the first four weeks. This is a tolerability dose: its job is to let your body adjust to semaglutide before the therapeutic doses arrive, reducing the likelihood of nausea and other gastrointestinal effects. After a month at 0.25 mg, the dose steps to 0.5 mg for four weeks, then 1.0 mg, then 1.7 mg, before reaching the standard 2.4 mg maintenance dose at around week seventeen. That's roughly five months of titration.

Each step happens approximately every four weeks, and the progression is guided by your prescriber rather than a fixed calendar, tolerability matters. Some people need more time at a lower dose before moving up. This is why how you take Wegovy for weight loss involves more than just the injection technique: the whole titration arc is a clinical process, not a self-managed one.

Since January 2026 there is also a licensed 7.2 mg maintenance dose, approved by the MHRA first as three concurrent 2.4 mg pens and then (from April 2026) as a dedicated single-dose 7.2 mg pen. Trials reported approximately 20.7% average weight loss over 72 weeks at this dose. It is approved for adults with obesity (BMI ≥30 only). The titration to 7.2 mg follows the same weekly schedule, starting at 0.25 mg, with the prescriber deciding at each step whether an increase is appropriate.

Practical details that affect how well the weekly schedule works

Consistency matters more than most people expect. Injecting on the same weekday each week (say, every Sunday morning) keeps the dosing interval as close to exactly seven days as possible, and our guide to how often you use Wegovy in practice covers what to do if that routine is disrupted. Shifting the day occasionally is sometimes unavoidable, but the gap between injections should stay as close to seven days as you can manage. Your prescriber and the Patient Information Leaflet will advise on what to do if a dose is genuinely missed.

Injection sites rotate between the abdomen, thigh, and upper arm. Rotating within and between these sites each week reduces the chance of local skin reactions. Storage between injections is in the fridge at 2–8°C; the SmPC specifies a limited window for room-temperature storage that you should follow from the Patient Information Leaflet rather than any general source.

For context on what using this treatment through a regulated UK service actually involves, the Wegovy treatment overview covers eligibility, the consultation process, and what to expect from the first pen onwards. If the cost side is something you're weighing up, the guide to where Wegovy is available in the UK walks through what legitimate private treatment costs and what to look for in a provider. Both are worth reading alongside this.

GI side effects and the weekly rhythm: what the timing usually looks like

Nausea, indigestion, and looser stools tend to be most noticeable in the day or two following an injection, particularly after a dose increase. For many people this settles within a couple of weeks as the body adjusts. The weekly schedule plays directly into this: because the peak concentration occurs in the 24–72 hours after each injection, the timing of meals and hydration on injection day (and the day after) can make a practical difference to comfort.

A useful overview of what to expect on this front is the guide to Wegovy and stomach discomfort, which covers the common gastrointestinal effects, when they usually ease, and what warrants contacting a clinician. Gut symptoms are also why the titration schedule exists, stepping up slowly gives the GI tract time to adapt between dose increases.

If you're thinking about starting treatment and want a prescriber to review your situation properly, you can start your free consultation with our team. A GPhC-registered Independent Prescriber reads every response the same day; no algorithms, no queues, just a clinical decision made by a named clinician.